Webinar: Is HIV Molecular Surveillance Worth The Risk? (2019)
On October 15, 2019, CHLP presented a webinar entitled Is HIV Molecular Surveillance Worth The Risk? to review the scientific and public health implications of HIV molecular surveillance, and discuss how this technology fits in with ongoing HIV criminalization advocacy. Panelists include Jacob Schneider, CHLP Staff Attorney; Andrew Gans, MPH, HIV, STD and Hepatitis Section Manager, New Mexico Department of Health; and, Ronald Johnson, US People Living with HIV Caucus.